Subscribe for email alerts
Donate to Science & Enterprise
|
By Alan, on September 9th, 2023%
The number of new infections from the human immunodeficiency virus or HIV declined worldwide last year and over the past decade, with the sharpest declines in sub-Saharan Africa. . . . → Read More: Infographic – HIV Infections Fall in Africa. Rise in Mideast, Europe
By Alan, on September 8th, 2023%
Researchers use stem cells to generate human neurons resembling those in the brain that control breathing during opioid reactions, for eventual chip devices to test overdose therapies. . . . → Read More: Neurons from Stem Cells Produced for Overdose Therapy Tests
By Alan, on September 5th, 2023%
Results of a clinical trial show a vaccine delivered as a nasal spray protects healthy people against infection from the bacteria causing whooping cough infections. . . . → Read More: Trial Shows Nasal Vaccine Reduces Whooping Cough Bacteria
By Alan, on August 22nd, 2023%
A company creating a digital process to monitor farm insect pests is receiving funds to expand its technology for tracking and counting mosquitoes as a general public health threat. . . . → Read More: Small Biz Award Funds A.I. Mosquito Monitoring System
By Alan, on July 24th, 2023%
A digital health company with an app for monitoring maternal health is receiving nearly $1 million to add an algorithm for detecting a dangerous pregnancy complication. . . . → Read More: Small Biz Award to Boost Maternal Health App
By Alan, on July 20th, 2023%
A treatment for HIV taken just once, using the genome-editing technology Crispr, is receiving fast-track designation from the U.S. Food and Drug Administration. . . . → Read More: One-Time Crispr HIV Therapy Given Fast-Track Status
By Alan, on June 16th, 2023%
A review of insurance claims shows patients facing obstacles to coverage for their migraine therapies are also more likely to need emergency care for treatment. . . . → Read More: Insurance Barriers, Migraine Hospital Visits Linked
By Alan, on June 9th, 2023%
A developer of detection systems for infections and university medical center plan a clinical trial to evaluate a sepsis device for helping patients with blood stream infections. . . . → Read More: Device Company, Medical Center Partner on Blood Infections Trial
By Alan, on June 2nd, 2023%
A genomic systems company created an artificial intelligence algorithm from primate genomic data that identifies possible disease-causing mutations in humans. . . . → Read More: Primate Genome A.I. Model IDs Human Disease Variants
By Alan, on May 27th, 2023%
A recent poll shows U.S. adults continue to favor vaccinations against the childhood diseases mumps, measles, and rubella, but show less support for Covid-19 vaccines. . . . → Read More: Infographic – More US Support for Childhood Vaccines Than Covid-19
|
Welcome to Science & Enterprise Science and Enterprise is an online news service begun in 2010, created for researchers and business people interested in taking scientific knowledge to the marketplace.
On the site’s posts published six days a week, you find research discoveries destined to become new products and services, as well as news about finance, intellectual property, regulations, and employment.
|